NetCE - Continuing Education Online
Home About NetCE Staff & Faculty  Contact  Us 
Read course content

Course # 90200 • Botulinum Toxin and Dermal Fillers for Facial Aging


Objective:
Discuss the mechanism of action and clinical use of botulinum toxin for the treatment of facial aging.

7. Which of the following is TRUE regarding onabotulinumtoxinA?
A) It was first marketed in Europe.
B) It is the original, most-studied formulation.
C) It is the only approved serotype-B formulation.
D) It is newer and less-studied, and FDA approval is pending.